Compared to in-person CME events, the cost savings for our client of moving all activities online were over 80%. Have a look through this case study to learn about using the Impetus InSite Platform® for #CME among other applications.

1. Total Participants
​100
Number of Touchpoints
3
Project Case Study » Using the Impetus InSite Platform®
for CME November – December 2018
Overview
In this series of 3 online touchpoints, our client leveraged the Impetus InSite
Platform®
to provide continuing medical education (CME) to 5 groups of 20
dermatologists spread throughout the USA. Each group included a moderator
to keep the discussions engaging.
Our client’s objectives were to:
1. Present the latest phase III clinical trial and real-world data on their
new product
2. Make the participants aware of the benefits of their product vs. its
comparators
3. Generate discussions on the clinical implications and applicability of
their product for various patient populations/indications based on the
presented data
Managed online solutions for life science
advisory boards, working groups, team
collaboration, and execution of continuing
medical education
Expertly Moderated

2. Touchpoint Breakdown
In the strategic planning stage of this project, Impetus Digital's experienced Account Managers helped execute the
client’s vision and provided recommendations on how to best present the clinical trial and real-world data to the
participants and how to effectively engage the participants in interactive discussions surrounding the presented data.
The Account Managers then worked with the client to develop a Campaign of Interactions®
(COI), which is a map of
the planned CME touchpoints – the number, type, and timing of touchpoints required to realize the client’s objectives.
In this series of CME touchpoints, two online asynchronous touchpoints and one 60-minute synchronous webinar
were scheduled in November and December 2018.
Touchpoint 1
The CME participants were presented
with pre-reading materials comprising
two phase III clinical trials and two
real-world studies on the client’s product
in different patient populations. In
addition to the full studies, slides
summarizing the most important data
were also provided. Subsequently, the
participants were asked a number of
questions related to their impressions of
the presented data and were able to
answer these, as well as reply to their
colleagues’ answers, on their own time.
Touchpoint 2
In the second touchpoint, the participants
were presented with three case studies in
different formats (text, photos, and a
short video) and asked about their
treatment decisions for these patients. In
particular, focus was placed on how and
where the client’s product fit in the
management of the patients, considering
the study data presented in Touchpoint 1.
Touchpoint 3
After wrapping up the two asynchronous
activities for all five groups, the client
held a real-time webinar for all
participants in which the first two
touchpoints were summarized and
ongoing/future clinical and real-world
studies on their product were discussed.
As part of the webinar, the client used
interactive mobile polling to ask a
number of multiple-choice questions to
gauge the participants’ current
knowledge and opinion on the product.
Web meetingCase StudiesGroup Discussion

3. The Results
By leveraging Impetus' best-in-class platform and technical support, the client was able to execute three online CME
touchpoints with large groups of participants in an impactful and cost-effective manner. The platform’s automated
project management and dedicated support team ensured the participants remained highly engaged over all three
touchpoints.
Overall Cost Savings Compared to
In-person CME Events
​81%
Overall Engagement Rate Throughout the
Campaign of Interactions®
95%
Average Attentiveness Score During
the Web Meeting
90%
Average Length of Participant Comments
per Asynchronous Touchpoint
663 words
Average Participant Feedback Score
Out of 10
8.9 (range: 6-10)
Participants Reporting “More Likely to Use
Client’s Product” After the CME touchpoints
88%
These results are in line with what is typically obtained using Impetus’ solution.

4. Key Participant Learnings
At the end of Touchpoint 1, the CME participants had become aware of the
most recent research on the client’s product, including the data showing its
efficacy and safety not only in clinical trials, but also in broader patient
populations in the real-world setting. Other features of the product such as
its side effects, acceptability to the patients, and impact on quality of life
were also explored.
1
After Touchpoint 2, the participants had learned about the benefits of
the product compared to its comparators by discussing its use in three
real case studies. After suggesting their own treatment strategies for
each case, the moderator revealed how the patients had been
successfully treated with the client’s product, including the dosing and
administration schedule used.
At the conclusion of Touchpoint 3, the participants were not only
aware of the current status of research into the product, but had also
gained insight into the ongoing and future studies planned in
different patient populations. They were given a summary of the data
presented in the previous touchpoints and were asked for their
feedback regarding the product itself and the current series of CME
activities. As a result, almost 90% of the participants stated that they
are now more likely to use the client’s product compared to at the
start of the COI.
2
3

5. Outcomes from the Client’s Campaign of Interactions®
Secure, compliant, and audit-friendly: Leveraging the Impetus InSite Platform’s®
security-first design,
data, including unpublished study results, were shared in a safe and secure manner. If needed, the client
will be able to quickly respond to an internal audit by leveraging the portal's built-in tracking and reporting
system.
Knowledge of Product’s Key Benefits: By reviewing the pre-reading materials and summary slides, and
subsequently responding to a number of discussion questions related to the clinical implications and key
findings from each study, all (100%) participants reported improved knowledge on the product and its
benefits after Touchpoint 1.
Understanding of Product’s Use in Different Patient Populations: By presenting three real case studies in
various formats, the participants built on the knowledge obtained in Touchpoint 1, discussing the
indications and benefits of the product for each type of patient. The interactive discussions among
dermatologists across the USA allowed many different practices and perspectives to be considered.
Substantial Cost Savings: Compared to arranging in-person CME events for dermatologists across the
country, the cost savings for the client by removing the need for travel, food, and speaker fees (among
other expenses) were over 80%.

6. Impetus Digital specializes in managed online solutions for life science advisory
boards, working groups, team collaboration, and execution of continuing medical
education.
Learn more about Impetus' best-in-class collaboration platform and consultative
services at impetusdigital.com.
“The online format was refreshing for delivering
CME. Although it’s always nice to catch up with
colleagues face to face, this was much more
convenient. Except for the live webinar, I was able to
finish all activities on my own time, usually in the
evening after the kids are asleep.”
Dermatologist
Salt Lake City, Utah
“Thanks to [Client] for putting together three different
and interesting activities. The case studies were my
favorite part.”
Dermatologist
Phoenix, Arizona
Client and Participant Feedback
“I enjoyed learning about [Product] and discussing the
different cases and studies with colleagues around
the country. I’m definitely more aware of [Product’s]
strengths and benefits compared to two months ago.”
Dermatologist
Oakland, California
impetusdigital.com
meetwithnatalie.com
connect@impetusdigital.com
“This was our first time using the Impetus platform
for medical education and we were honestly blown
away by the results. We are planning to conduct a
second round of touchpoints for more dermatologists
in 2019 and are excited for an ongoing relationship
with Impetus as new data are becoming available and
the indications for [Product] are expanding!”
Senior Product Manager, Client